Natera [NTRA] vs Thermo Fisher [TMO] Detailed Stock Comparison
Natera
NASDAQ
Loading...
Thermo Fisher
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Natera wins in 5 metrics, Thermo Fisher wins in 12 metrics, with 0 ties. Thermo Fisher appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Natera | Thermo Fisher | Better |
|---|---|---|---|
| P/E Ratio (TTM) | N/A | 28.17 | N/A |
| Price-to-Book Ratio | 16.68 | 3.64 | Thermo Fisher |
| Debt-to-Equity Ratio | 14.69 | 69.62 | Natera |
| PEG Ratio | -125.58 | 4.96 | Natera |
| EV/EBITDA | -75.94 | 19.69 | Natera |
| Profit Margin (TTM) | -12.89% | 15.24% | Thermo Fisher |
| Operating Margin (TTM) | -20.19% | 17.84% | Thermo Fisher |
| EBITDA Margin (TTM) | N/A | 17.84% | N/A |
| Return on Equity | -24.32% | 13.42% | Thermo Fisher |
| Return on Assets (TTM) | -11.21% | 4.97% | Thermo Fisher |
| Free Cash Flow (TTM) | $58.75M | $7.27B | Thermo Fisher |
| Dividend Yield | N/A | 0.31% | N/A |
| 1-Year Return | 31.49% | -17.51% | Natera |
| Price-to-Sales Ratio (TTM) | 10.62 | 4.26 | Thermo Fisher |
| Enterprise Value | $19.95B | $213.03B | Thermo Fisher |
| EV/Revenue Ratio | 10.16 | 4.93 | Thermo Fisher |
| Gross Profit Margin (TTM) | 63.12% | 40.61% | Natera |
| Revenue per Share (TTM) | $15 | $114 | Thermo Fisher |
| Earnings per Share (Diluted) | $-1.91 | $17.31 | Thermo Fisher |
| Beta (Stock Volatility) | 1.76 | 0.75 | Thermo Fisher |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Natera vs Thermo Fisher Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Natera | 0.51% | 7.29% | 8.79% | 9.12% | -3.75% | 1.51% |
| Thermo Fisher | 3.36% | 2.25% | 16.93% | 24.85% | -6.64% | -4.32% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Natera | 31.49% | 223.65% | 147.45% | 1,046.41% | 805.67% | 805.67% |
| Thermo Fisher | -17.51% | -11.30% | 17.79% | 295.19% | 1,057.92% | 1,679.96% |
Performance & Financial Health Analysis: Natera vs Thermo Fisher
| Metric | NTRA | TMO |
|---|---|---|
| Market Information | ||
| Market Cap | $20.85B | $184.10B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 1,986,050 | 2,020,610 |
| 90 Day Avg. Volume | 1,509,673 | 2,900,827 |
| Last Close | $171.86 | $500.00 |
| 52 Week Range | $92.14 - $183.00 | $385.46 - $627.88 |
| % from 52W High | -6.09% | -20.37% |
| All-Time High | $183.00 (Jan 13, 2025) | $672.34 (Dec 27, 2021) |
| % from All-Time High | -6.09% | -25.63% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.32% | 0.03% |
| Quarterly Earnings Growth | N/A | 0.05% |
| Financial Health | ||
| Profit Margin (TTM) | -0.13% | 0.15% |
| Operating Margin (TTM) | -0.20% | 0.18% |
| Return on Equity (TTM) | -0.24% | 0.13% |
| Debt to Equity (MRQ) | 14.69 | 69.62 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $9.11 | $133.77 |
| Cash per Share (MRQ) | $7.43 | $16.92 |
| Operating Cash Flow (TTM) | $91.06M | $7.58B |
| Levered Free Cash Flow (TTM) | $-116,962,992 | $5.18B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.31% |
| Last 12-Month Dividend | N/A | $1.21 |
Valuation & Enterprise Metrics Analysis: Natera vs Thermo Fisher
| Metric | NTRA | TMO |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | N/A | 28.17 |
| Forward P/E | -125.58 | 20.76 |
| PEG Ratio | -125.58 | 4.96 |
| Price to Sales (TTM) | 10.62 | 4.26 |
| Price to Book (MRQ) | 16.68 | 3.64 |
| Market Capitalization | ||
| Market Capitalization | $20.85B | $184.10B |
| Enterprise Value | $19.95B | $213.03B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 10.16 | 4.93 |
| Enterprise to EBITDA | -75.94 | 19.69 |
| Risk & Other Metrics | ||
| Beta | 1.76 | 0.75 |
| Book Value per Share (MRQ) | $9.11 | $133.77 |
Financial Statements Comparison: Natera vs Thermo Fisher
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | NTRA | TMO |
|---|---|---|
| Revenue/Sales | $501.83M | $10.36B |
| Cost of Goods Sold | $185.07M | $6.13B |
| Gross Profit | $316.77M | $4.24B |
| Research & Development | $129.08M | $342.00M |
| Operating Income (EBIT) | $-79.18M | $1.82B |
| EBITDA | $-56.52M | $2.73B |
| Pre-Tax Income | $-66.76M | $1.62B |
| Income Tax | $173,000 | $95.00M |
| Net Income (Profit) | $-66.94M | $1.51B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | NTRA | TMO |
|---|---|---|
| Cash & Equivalents | $973.77M | $4.13B |
| Total Current Assets | $1.42B | $23.38B |
| Total Current Liabilities | $365.68M | $13.17B |
| Long-Term Debt | $103.06M | $31.37B |
| Total Shareholders Equity | $1.24B | $49.49B |
| Retained Earnings | $-2.63B | $54.45B |
| Property, Plant & Equipment | $94.63M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | NTRA | TMO |
|---|---|---|
| Operating Cash Flow | $12.99M | $2.15B |
| Capital Expenditures | $-21.82M | $-350.00M |
| Free Cash Flow | $22.64M | $361.00M |
| Debt Repayment | N/A | $-838.00M |
| Common Stock Repurchase | N/A | $-2.00B |
Short Interest & Institutional Ownership Analysis
| Metric | NTRA | TMO |
|---|---|---|
| Shares Short | 3.72M | 3.71M |
| Short Ratio | 2.92 | 1.14 |
| Short % of Float | 0.03% | 0.01% |
| Average Daily Volume (10 Day) | 1,986,050 | 2,020,610 |
| Average Daily Volume (90 Day) | 1,509,673 | 2,900,827 |
| Shares Outstanding | 132.65M | 380.77M |
| Float Shares | 132.36M | 376.76M |
| % Held by Insiders | 0.03% | 0.00% |
| % Held by Institutions | 0.96% | 0.92% |
Dividend Analysis & Yield Comparison: Natera vs Thermo Fisher
| Metric | NTRA | TMO |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.21 |
| Last 12-Month Dividend Yield | N/A | 0.31% |
| 3-Year Avg Annual Dividend | N/A | $1.33 |
| 3-Year Avg Dividend Yield | N/A | 0.07% |
| 3-Year Total Dividends | N/A | $3.99 |
| Ex-Dividend Date | N/A | Mar 14, 2025 |